The potential of targeting microRNA-23b-3p signaling in Alzheimer’s disease: opinions on recent findings

Frontiers in Pharmacology

Pharmacology

Zhongdi Cai¹  Zhuorong Li¹  Chenyu Wang¹  Rui Liu² 

[1] Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;null;

关键词: Alzheimer’s disease;    microRNA-23b-3p;    microRNA therapy;    glycogen synthase kinase-3β;    tau protein;   

DOI  :  10.3389/fphar.2023.1245352

 received in 2023-06-23, accepted in 2023-07-03,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Wang, Cai, Li and Liu.